We are live on ! Find out more
BBH icon

VanEck Biotech ETF
BBH

98 hedge funds and large institutions have $115M invested in VanEck Biotech ETF in 2025 Q2 according to their latest regulatory filings, with 10 funds opening new positions, 15 increasing their positions, 25 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

0.61% less ownership

Funds ownership: 35.45% → 34.84% (-0.61%)

6% less funds holding

Funds holding: 104 → 98 (-6)

11% less capital invested

Capital invested by funds: $130M → $115M (-$14.3M)

38% less first-time investments, than exits

New positions opened: 10 | Existing positions closed: 16

40% less repeat investments, than reductions

Existing positions increased: 15 | Existing positions reduced: 25

57% less call options, than puts

Call options by funds: $276K | Put options by funds: $644K

Holders
98
Holders Change
-6
Holders Change %
-5.77%
% of All Funds
1.29%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
10
Increased
15
Reduced
25
Closed
16
Calls
$276K
Puts
$644K
Net Calls
-$368K
Net Calls Change
-$2.77M

Top Buyers

Rank Fund Capital Flow
1
Raymond James Financial
Raymond James Financial
Florida
+$7.19M
2
BFG
Bleakley Financial Group
New Jersey
+$2.83M
3
Bank of America
Bank of America
North Carolina
+$1.18M
4
Citadel Advisors
Citadel Advisors
Florida
+$840K
5
Citigroup
Citigroup
New York
+$816K

Top Sellers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
-$6.8M
2
Wells Fargo
Wells Fargo
California
-$5.13M
3
Northwestern Mutual Wealth Management
Northwestern Mutual Wealth Management
Wisconsin
-$3.11M
4
Commonwealth Equity Services
Commonwealth Equity Services
Massachusetts
-$2.66M
5
MIM
Miller Investment Management
Pennsylvania
-$1.54M
Name Holding Trade Value Shares
Change 		Change in
Stake
Osaic Holdings
51
Osaic Holdings
Arizona
$225K +$102K +682 +87%
HFAS
52
Hummer Financial Advisory Services
Illinois
$216K – – –
RSWM
53
Robertson Stephens Wealth Management
California
$215K +$7.45K +50 +4%
Creative Planning
54
Creative Planning
Kansas
$211K -$54.7K -367 -21%
TSWM
55
Tyler-Stone Wealth Management
Ohio
$201K – – –
BCV
56
Banque Cantonale Vaudoise
Switzerland
$185K +$180K +1,206 New
WSFS
57
Wilmington Savings Fund Society
Delaware
$158K +$2.68K +18 +2%
UB
58
UMB Bank
Missouri
$138K – – –
EPAM
59
Evelyn Partners Asset Management
$123K – – –
Comerica Bank
60
Comerica Bank
Texas
$103K – – –
SS
61
SBI Securities
Japan
$66.2K +$149 +1 +0.2%
William Blair & Company
62
William Blair & Company
Illinois
$65.1K – – –
NSIM
63
North Star Investment Management
Illinois
$57.2K – – –
AAS
64
Ameritas Advisory Services
Nebraska
$56.9K +$55.3K +371 New
Fidelity Investments
65
Fidelity Investments
Massachusetts
$50.9K +$447 +3 +0.9%
LFASL
66
Lugano Financial Advisors SA (LFA)
Switzerland
$47.5K – – –
FWM
67
FSA Wealth Management
Massachusetts
$46.7K – – –
MCM
68
Manchester Capital Management
Vermont
$46K – – –
Bank of Montreal
69
Bank of Montreal
Ontario, Canada
$44K – – –
MCM
70
MAI Capital Management
Ohio
$40.6K – – –
TC
71
Truvestments Capital
Florida
$38.3K – – –
HI
72
Harbour Investments
Wisconsin
$36K – – –
CT
73
Caldwell Trust
Florida
$34.5K – – –
Carson Wealth (CWM LLC)
74
Carson Wealth (CWM LLC)
Nebraska
$34K – – –
T
75
Tidemark
California
$31.7K – – –
1 2
3
4 5

BBH Hedge Fund Activity: Q2 2025 in Review

98 of the 7,595 institutional investors tracked by Wall St. Rank reported a position in VanEck Biotech ETF (BBH) for Q2 2025, worth a combined $115M — down 11% from $130M a quarter earlier.

Sellers outnumbered buyers: 16 funds closed out of BBH and 10 opened new positions — a net loss of 6 holders — while 25 trimmed existing stakes and 15 added.

The largest buyer was Raymond James Financial, adding an estimated $7.19M. The largest seller was Morgan Stanley, cutting an estimated $6.8M.

  • 98 institutional investors held VanEck Biotech ETF (BBH) as of Q2 2025, down from 104 in Q1 2025.
  • Funds reported $115M of VanEck Biotech ETF stock for Q2 2025, down 11% quarter-over-quarter.
  • 10 funds opened new VanEck Biotech ETF positions in Q2 2025 and 16 closed out, a net change of -6 holders.
  • The largest VanEck Biotech ETF buyer in Q2 2025 was Raymond James Financial, an estimated $7.19M added.
  • The largest VanEck Biotech ETF seller in Q2 2025 was Morgan Stanley, an estimated $6.8M sold.

Based on aggregated 13F filings for Q2 2025.